CEO
RealSeq Biosciences
Sergio Barberan-Soler is the founder and CEO of RealSeq Biosciences, the leader in groundbreaking RNA fragmentomics technology to allow real-time detection of disease. He is an inventor, patent holder, and National Institutes of Health (NIH) sponsored researcher. Sergio has extensive training in RNA biology and is the author on more than 15 scientific publications spanning basic RNA research, novel RNA technologies, and bioinformatic analysis. RealSeq has focused on developing innovative technologies for detection of circulating small RNAs and RNA fragments. We partner with both academia and Pharma/biotech to facilitate biomarker discovery projects using cutting edge RNA detection technologies. Sergio holds Ph.D. in Molecular, Cell and Developmental Biology from the University of California, Santa Cruz.